Literature DB >> 21797767

Pulmonary inflammatory and fibrotic responses in Fischer 344 rats after intratracheal instillation exposure to Libby amphibole.

Danielle J Padilla-Carlin1, Mette C J Schladweiler, Jonathan H Shannahan, Urmila P Kodavanti, Abraham Nyska, Lyle D Burgoon, Stephen H Gavett.   

Abstract

Increased incidences of asbestosis have been reported in workers from Libby, MT, associated with exposures to amphibole-contaminated vermiculite. In this study pulmonary and histopathological changes were investigated following Libby amphibole (LA) exposure in a rat model. Rat respirable fractions of LA and amosite (aerodynamic diameter <2.5 μm) were prepared by water elutriation. Male F344 rats were exposed to single doses of either saline (SAL), amosite (0.65 mg/rat), or LA (0.65 or 6.5 mg/rat) by intratracheal instillation. At times from 1 d to 3 mo after exposure, bronchoalveolar lavage (BAL) was performed and right and left lungs were removed for reverse-transcription polymerase chain reaction (RT-PCR) and histopathological analysis, respectively. Data indicated that 0.65 mg amosite resulted in a higher degree of pulmonary injury, inflammation, and fibrotic events than LA at the same mass dose. Exposure to either amosite or high dose LA resulted in higher levels of cellular permeability and injury, inflammatory enzymes, and iron binding proteins in both BAL fluid and lung tissue at most time points when compared to SAL controls. However, mRNA expression for some growth factors (e.g., platelet-derived growth factor [PDGF]-A and transforming growth factor [TGF]-1β), which contribute to fibrosis, were downregulated at several time points. Furthermore, histopathological examination showed notable thickening of interstitial areas surrounding the alveolar ducts and terminal bronchioles. On a mass dose basis, amosite produced a greater acute and persistent lung injury for at least 3 mo after exposure. However, further testing and analysis of LA are needed with regard to the dose metric to fully evaluate its potential fibrogenicity and carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797767     DOI: 10.1080/15287394.2011.586940

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  8 in total

1.  Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits Libby amphibole fiber-induced acute inflammation in mice.

Authors:  Melpo Christofidou-Solomidou; Ralph A Pietrofesa; Kyewon Park; Steven M Albelda; Kinta M Serve; Deborah E Keil; Jean C Pfau
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-23       Impact factor: 4.219

Review 2.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

3.  Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Vivianne L Verissimo; Jessica A Cervelli; Kinal N Vayas; LeRoy Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2015-08-04       Impact factor: 4.849

4.  In vitro determinants of asbestos fiber toxicity: effect on the relative toxicity of Libby amphibole in primary human airway epithelial cells.

Authors:  Kelly E Duncan; Philip M Cook; Stephen H Gavett; Lisa A Dailey; Ron K Mahoney; Andrew J Ghio; Victor L Roggli; Robert B Devlin
Journal:  Part Fibre Toxicol       Date:  2014-01-08       Impact factor: 9.400

Review 5.  Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.

Authors:  Jun Tashiro; Gustavo A Rubio; Andrew H Limper; Kurt Williams; Sharon J Elliot; Ioanna Ninou; Vassilis Aidinis; Argyrios Tzouvelekis; Marilyn K Glassberg
Journal:  Front Med (Lausanne)       Date:  2017-07-28

6.  Cytopathological Findings in Bronchoalveolar Lavage from Patients with COVID-19.

Authors:  Silvio Antonio Galeano Reyes; Patricia Dhimes Tejeda; Bárbara Steen; Hansely Keret Arcos Orozco; Paloma Ramos Pontón
Journal:  Acta Cytol       Date:  2022-06-22       Impact factor: 3.000

7.  Cytopathology of bronchoalveolar lavages in COVID___19 pneumonia: A pilot study.

Authors:  Valentina Canini; Francesca Bono; Paolo Calzavacca; Giulia Capitoli; Giuseppe Foti; Filippo Fraggetta; Stefania Galimberti; Andrea Gianatti; Marco Giani; Ahmed Nasr; Giuseppe Paciocco; Fabio Pagni; Roberto Rona; Vincenzo L'Imperio
Journal:  Cancer Cytopathol       Date:  2021-03-10       Impact factor: 4.264

8.  Current Research and Opportunities to Address Environmental Asbestos Exposures.

Authors:  Danielle J Carlin; Theodore C Larson; Jean C Pfau; Stephen H Gavett; Arti Shukla; Aubrey Miller; Ronald Hines
Journal:  Environ Health Perspect       Date:  2015-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.